Article Sidebar

Submitted
January 4, 2024
Accepted
January 4, 2024
Published
January 4, 2024
Download
PDF
Statistic
Read Counter : 244 Download : 244

Main Article Content

Abstract

Pseudomonas aeruginosa is characterized by that it is associated with many morbidities and
deaths for people with immunodeficiency, as well as people who visit hospitals frequently and
patients with burns, especially severe ones, because the bacteria are Gram-negative, opportunistic,
and cause severe infections. The study included 45 samples that isolated the advanced aeruginosa
bacteria from moderately burned men and women, their ages ranged between 12 to 60 years. The
purpose of the study was to investigate the susceptibility of P. aeruginosa to resistance to some
antibiotics for the purpose of controlling the incidence of wound infection in patients with burns.
The phenotypic pattern of the bacteria under study shows that there is severe resistance to some
antibiotics, while the bacteria are unable to resist some other antibiotics.

Article Details

License

Copyright (c) 2024 University of Thi-Qar Journal Of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Maroui, I., Barguigua, A., Aboulkacem, A., Elhafa, H., Ouarrak, K., Sbiti, M., ... & Belhaj, A.
  2. (2017). Clonal analysis of clinical and environmental Pseudomonas aeruginosa isolates from Meknes
  3. region, Morocco. Polish Journal of Microbiology, 66(3).
  4. Schaber, J. A., Hammond, A., Carty, N. L., Williams, S. C., Colmer-Hamood, J. A., Burrowes, B.
  5. H., ... & Hamood, A. N. (2007). Diversity of biofilms produced by quorum-sensing-deficient clinical
  6. isolates of Pseudomonas aeruginosa. Journal of medical microbiology, 56(6), 738-748.
  7. Alikhani, M. Y., Parsavash, S., Arabestani, M. R., & Hosseini, S. M. (2017). Prevalence of antibiotic
  8. resistance and class 1 integrons in clinical and environmental isolates of Pseudomonas
  9. aeruginosa. Avicenna Journal of Clinical Microbiology and Infection, 4(4), 12086-12086.
  10. Davane, M., Suryawanshi, N., Pichare, A., & Nagoba, B. S. (2014). Pseudomonas aeruginosa from
  11. hospital environment. Journal of Microbiology and Infectious Diseases, 4(01).
  12. de Abreu, P. M., Farias, P. G., Paiva, G. S., Almeida, A. M., & Morais, P. V. (2014). Persistence of
  13. microbial communities including Pseudomonas aeruginosa in a hospital environment: a potential health
  14. hazard. BMC microbiology, 14(1), 1-10.
  15. Karami P., Mohajeri P., Mashouf R. Y., Karami M., Yaghoobi M. H., Dastan D., Alikhani M. Y.
  16. (2019). Molecular characterization of clinical and environmental Pseudomonas aeruginosa isolated in a
  17. burn center, Saudi Journal of Biological Sciences, Volume 26, Issue 7, Pages 1731-1736.
  18. Hassuna, N. A., Mohamed, A. H. I., Abo-Eleuoon, S. M., & Rizk, H. A. W. A. (2015). High
  19. prevalence of multidrug resistant Pseudomonas aeru. Archives of Clinical Microbiology, 6(4).
  20. Karami, P., Bazmamoun, H., Sedighi, I., Nejad, A. S. M., Aslani, M. M., & Alikhani, M. Y. (2017).
  21. Antibacterial resistance patterns of extended spectrum β-lactamase-producing enteropathogenic
  22. Escherichia coli strains isolated from children. Arab Journal of Gastroenterology, 18(4), 206-209.
  23. Schaber, J. A., Hammond, A., Carty, N. L., Williams, S. C., Colmer-Hamood, J. A., Burrowes, B.
  24. H., ... & Hamood, A. N. (2007). Diversity of biofilms produced by quorum-sensing-deficient clinical
  25. isolates of Pseudomonas aeruginosa. Journal of medical microbiology, 56(6), 738-748.
  26. Alikhani, M. Y., Tabar, Z. K., Mihani, F., Kalantar, E., Karami, P., Sadeghi, M., ... & Farajnia,
  27. S. (2014). Antimicrobial resistance patterns and prevalence of blaPER-1 and blaVEB-1 genes among
  28. ESBL-producing Pseudomonas aeruginosa isolates in West of Iran. Jundishapur Journal of
  29. Microbiology, 7(1).
  30. Safari, M., Alikhani, M. Y., Arabestani, M. R., Kakhki, R. K., & Jafari, R. (2014). Prevalence of
  31. Metallo-β-lactamases encoding genes among pseudomonas aeruginosa strains isolated from the bedridden
  32. patients in the intensive care units. Avicenna Journal of Clinical Microbiology and Infection, 1(1), 19216-
  33. Rasamiravaka, T., Labtani, Q., Duez, P., & El Jaziri, M. (2015). The formation of biofilms by
  34. Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control
  35. mechanisms. BioMed research international, 2015.
  36. Rasamiravaka, T., Vandeputte, O. M., Pottier, L., Huet, J., Rabemanantsoa, C., Kiendrebeogo,
  37. M., ... & El Jaziri, M. (2015). Pseudomonas aeruginosa biofilm formation and persistence, along with the
  38. production of quorum sensing-dependent virulence factors, are disrupted by a triterpenoid coumarate ester
  39. isolated from Dalbergia trichocarpa, a tropical legume. PloS one, 10(7), e0132791.
  40. Chemaly, R. F., Simmons, S., Dale Jr, C., Ghantoji, S. S., Rodriguez, M., Gubb, J., ... & Stibich,
  41. M. (2014). The role of the healthcare environment in the spread of multidrug-resistant organisms: update
  42. on current best practices for containment. Therapeutic advances in infectious disease, 2(3-4), 79-90.
  43. Oliveira, A. C. D., & Damasceno, Q. S. (2010). Surfaces of the hospital environment as possible
  44. deposits of resistant bacteria: a review. Revista da Escola de Enfermagem da USP, 44(4), 1118-1123.
  45. Sadikot RT, Blackwell TS, Christman JW, Prince AS.( 2005). Pathogen–host interactions
  46. in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med.;171(11):1209–1223.
  47. Lister PD, Wolter DJ, Hanson ND. (2009). Antibacterial-resistant Pseudomonas aeruginosa: clinical
  48. impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol
  49. Rev.;22(4):582–610.
  50. Pitten, F. A., Panzig, B., Schröder, G., Tietze, K., & Kramer, A. (2001). Transmission of a
  51. multiresistant Pseudomonas aeruginosa strain at a German University Hospital. Journal of Hospital
  52. Infection, 47(2), 125-130.
  53. Climo, M. W., Pastor, A., & Wong, E. S. (1997). An outbreak of Pseudomonas aeruginosa related to
  54. contaminated urodynamic equipment. Infection Control & Hospital Epidemiology, 18(7), 509-510.
  55. Moolenaar, R. L., Crutcher, J. M., San Joaquin, V. H., Sewell, L. V., Hutwagner, L. C., Carson,
  56. L. A., ... & Jarvis, W. R. (2000). A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive
  57. care unit did staff fingernails play a role in disease transmission?. Infection Control & Hospital
  58. Epidemiology, 21(2), 80-85.
  59. Hassuna, N. A., Mohamed, A. H. I., Abo-Eleuoon, S. M., & Rizk, H. A. W. A. (2015). High
  60. prevalence of multidrug resistant Pseudomonas aeru. Archives of Clinical Microbiology, 6(4).
  61. luit, A. C., J. Verhoef, F. J. Schmitz, and The European SENTRY Participants (2001). Frequency
  62. of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in
  63. intensive care units of 25 European university hospitals participating in the European arm of the SENTRY
  64. Antimicrobial Surveillance Program 1997-1998. Eur. J. Clin. Microbiol. Infect. Dis.20:617-625.
  65. Livermore, D. M.2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:
  66. our worst nightmare? Clin. Infect. Dis.34:634-640.
  67. Stanković-Nedeljković, N., Tiodorović, B., Kocić, B., Ćirić, V., Milojković, M., & Waisi, H. (2015).
  68. Pseudomonas aeruginosa serotypes and resistance to antibiotics from wound swabs. Vojnosanitetski
  69. pregled, 72(11), 996-1003.
  70. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., ... &
  71. Monnet, D. L. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an
  72. international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology
  73. and infection, 18(3), 268-281.
  74. Jovcic, B., Lepsanovic, Z., Suljagic, V., Rackov, G., Begovic, J., Topisirovic, L., & Kojic, M.
  75. (2011). Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from
  76. Serbia. Antimicrobial agents and chemotherapy, 55(8), 3929-3931.
  77. Sardelic, S., Bedenic, B., Colinon-Dupuich, C., Orhanovic, S., Bosnjak, Z., Plecko, V., ... &
  78. Rossolini, G. M. (2012). Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant
  79. Pseudomonas aeruginosa strains from Croatia. Antimicrobial agents and chemotherapy, 56(5), 2746-2749.
  80. Hassuna, N. A., Mohamed, A. H. I., Abo-Eleuoon, S. M., & Rizk, H. A. W. A. (2015). High
  81. prevalence of multidrug resistant Pseudomonas aeru. Archives of Clinical Microbiology, 6(4).
  82. de Almeida, K. D. C. F., Calomino, M. A., Deutsch, G., de Castilho, S. R., de Paula, G. R., Esper,
  83. L. M. R., & Teixeira, L. A. (2017). Molecular characterization of multidrug-resistant (MDR)
  84. Pseudomonas aeruginosa isolated in a burn center. Burns, 43(1), 137-143.
  85. Taylor, P. K., Yeung, A. T., & Hancock, R. E. (2014). Antibiotic resistance in Pseudomonas
  86. aeruginosa biofilms: towards the development of novel anti-biofilm therapies. Journal of biotechnology,
  87. , 121-130.
  88. Gurung, J., Khyriem, A. B., Banik, A., Lyngdoh, W. V., Choudhury, B., & Bhattacharyya, P.
  89. (2013). Association of biofilm production with multidrug resistance among clinical isolates of
  90. Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian journal of critical
  91. care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine, 17(4), 214.
  92. Yekani, M., Memar, M. Y., Alizadeh, N., Safaei, N., & Ghotaslou, R. (2017). Antibiotic resistance
  93. patterns of biofilm-forming Pseudomonas aeruginosa isolates from mechanically ventilated patients.
  94. International Journal of Scientific Study, 5(5), 1-5.
  95. Karami, P., Mohajeri, P., Yousefi Mashouf, R., Karami, M., Yaghoobi, M. H., Dastan, D., &
  96. Alikhani, M. Y. (2019). Molecular characterization of clinical and environmental Pseudomonas aeruginosa
  97. isolated in a burn center. Saudi journal of biological sciences, 26(7), 1731–1736.
  98. Haeili, M., Ghodousi, A., Nomanpour, B., Omrani, M., & Feizabadi, M. M. (2013). Drug resistance
  99. patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-
  100. The Journal of Infection in Developing Countries, 7(04), 312-317.
  101. Singh, A., Goering, R. V., Simjee, S., Foley, S. L., & Zervos, M. J. (2006). Application of molecular
  102. techniques to the study of hospital infection. Clinical microbiology reviews, 19(3), 512-530.
  103. Haeili, M., Ghodousi, A., Nomanpour, B., Omrani, M., & Feizabadi, M. M. (2013). Drug resistance
  104. patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-
  105. The Journal of Infection in Developing Countries, 7(04), 312-317.
  106. Cunha BA. (2002). Pseudomonas aeruginosa: resistance and therapy. Semin Respir Infect.
  107. Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A. (2009). Pseudomonas aeruginosa
  108. padermiu, sukelusiu bakteriemija, sasajos su infekcijos zidiniu ir ju atsparumas antibiotikams
  109. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
  110. Medicina (Kaunas).;45(1):1-7. Lithuanian. PMID: 19223699